Search - tctmd.com

Displaying 281 - 300 of 404

Sort: Relevancy | Date

News Daily News

Vulnerable Plaque Components Seen on IVUS Not Linked With MACE, Two New Studies Show

Michael O'Riordan

October 17, 2018

News Daily News

Elevated Lp(a), Even in Statin-Treated Patients, Linked With Higher CVD Risks

Michael O'Riordan

October 15, 2018

News Daily News

Statin Benefits: Yes for CVD but No for Everything Else, Says New Review

Michael O'Riordan

October 08, 2018

News Daily News

Aspirin Falters Yet Again in Primary Prevention: ASPREE

Michael O'Riordan

September 17, 2018

News Conference News ESC 2018

ASCOT Legacy: Calcium Channel Blockers, Statins Confer Long-term Survival Benefits in Hypertensive Patients

L.A. McKeown

August 31, 2018

News Conference News ESC 2018

Sobering News From Europe: CVD Risk Factors Are on the Rise or Holding Firm

Todd Neale

August 27, 2018

News Conference News ESC 2018

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

Michael O'Riordan

August 26, 2018

News Daily News

High LDL and Non-HDL Cholesterol Tied to CV Mortality Even in Low-Risk Individuals

Lucy Hicks

August 21, 2018

News Daily News

Elevated High-Sensitivity CRP Lingers Long After MI, Observational Study Shows

Yael L. Maxwell

August 03, 2018

News Daily News

Starting Low and Going Lower: Some Benefit to Very Low LDL Levels

Michael O'Riordan

August 02, 2018

News Daily News

Peer Pressure May Push Physicians to Do Better at Prescribing Statins

Lucy Hicks

July 30, 2018

News Conference News SCCT 2018

CAC Scoring Enthusiasts Frustrated Over ‘Disappointing’ USPSTF Recommendations

Yael L. Maxwell

July 16, 2018

News Daily News

USPSTF: Insufficient Evidence to Support CAC Score, hsCRP, or ABI for Risk Assessment

Michael O'Riordan

July 12, 2018

News Daily News

High CVD Risk in India Varies by State, Demographics

Todd Neale

June 20, 2018

News Daily News

Serial CTA Shines a Light on Statin Effects in Subclinical CAD

Yael L. Maxwell

June 15, 2018

News Daily News

Among African Americans in Need of LDL Lowering: Less Statin Use, More Distrust of Doctors

Michael O'Riordan

June 13, 2018

News Conference News EAS 2018

Glucose and Beyond? Experts Debate Optimal Targets for Managing CV Risk in Diabetics

Yael L. Maxwell

May 16, 2018

News Conference News EAS 2018

EAS Consensus Document Examines Safety of Statins Beyond Muscle Symptoms

Yael L. Maxwell

May 11, 2018

News Conference News EAS 2018

Can Clinicians Really Put a Stop to Atherosclerosis? Experts Explore the How and When of CVD Prevention

Yael L. Maxwell

May 07, 2018

News Conference News EAS 2018

Biology in the Back Seat: EAS 2018 Opens With Calls for a Big-Picture Approach to CVD Prevention

Yael L. Maxwell

May 07, 2018

Advertisement

Vulnerable Plaque Components Seen on IVUS Not Linked With MACE, Two New Studies Show

Elevated Lp(a), Even in Statin-Treated Patients, Linked With Higher CVD Risks

Statin Benefits: Yes for CVD but No for Everything Else, Says New Review

Aspirin Falters Yet Again in Primary Prevention: ASPREE

ASCOT Legacy: Calcium Channel Blockers, Statins Confer Long-term Survival Benefits in Hypertensive Patients

Sobering News From Europe: CVD Risk Factors Are on the Rise or Holding Firm

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

High LDL and Non-HDL Cholesterol Tied to CV Mortality Even in Low-Risk Individuals

Elevated High-Sensitivity CRP Lingers Long After MI, Observational Study Shows

Starting Low and Going Lower: Some Benefit to Very Low LDL Levels

Peer Pressure May Push Physicians to Do Better at Prescribing Statins

CAC Scoring Enthusiasts Frustrated Over ‘Disappointing’ USPSTF Recommendations

USPSTF: Insufficient Evidence to Support CAC Score, hsCRP, or ABI for Risk Assessment

High CVD Risk in India Varies by State, Demographics

Serial CTA Shines a Light on Statin Effects in Subclinical CAD

Among African Americans in Need of LDL Lowering: Less Statin Use, More Distrust of Doctors

Glucose and Beyond? Experts Debate Optimal Targets for Managing CV Risk in Diabetics

EAS Consensus Document Examines Safety of Statins Beyond Muscle Symptoms

Can Clinicians Really Put a Stop to Atherosclerosis? Experts Explore the How and When of CVD Prevention

Biology in the Back Seat: EAS 2018 Opens With Calls for a Big-Picture Approach to CVD Prevention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content